Cargando…

The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma

Basal cell carcinoma (BCC) is an increasingly common cancer. For high‐risk BCCs, there are several treatment options, with similar efficacies. The current best practice in deciding upon a particular treatment is for a patient‐centred approach. At present, there are few resources available for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Banks, Jamie, Odili, Joy, Zaidi, Shane, Lalondrelle, Susan, Singh, Masha, Akhras, Victoria, Jiyad, Zainab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804260/
https://www.ncbi.nlm.nih.gov/pubmed/35799319
http://dx.doi.org/10.1111/ced.15325
_version_ 1784862066648023040
author Banks, Jamie
Odili, Joy
Zaidi, Shane
Lalondrelle, Susan
Singh, Masha
Akhras, Victoria
Jiyad, Zainab
author_facet Banks, Jamie
Odili, Joy
Zaidi, Shane
Lalondrelle, Susan
Singh, Masha
Akhras, Victoria
Jiyad, Zainab
author_sort Banks, Jamie
collection PubMed
description Basal cell carcinoma (BCC) is an increasingly common cancer. For high‐risk BCCs, there are several treatment options, with similar efficacies. The current best practice in deciding upon a particular treatment is for a patient‐centred approach. At present, there are few resources available for patients to assist their choice. This reduces patient autonomy and increases the burden on clinicians within clinic. Patient decision aids (PDAs) have been shown to increase patient autonomy and facilitate shared decision‐making. Currently, there is no published PDA designed to facilitate the decision between surgical management or radiotherapy in high‐risk BCCs. We developed a novel decision aid designed along the International Patient Decision Aid Standards to fill this clinical need, and evaluated its acceptance by both patients and clinicians. We describe the challenges faced at initial alpha and subsequent beta testing, and go on to validate our PDA with both the Decisional Conflict Scale and the nine‐item Shared Decision Making Questionnaire (SDMQ9). We include an example of the PDA and encourage other units to modify the PDA for their own use.
format Online
Article
Text
id pubmed-9804260
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98042602023-01-03 The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma Banks, Jamie Odili, Joy Zaidi, Shane Lalondrelle, Susan Singh, Masha Akhras, Victoria Jiyad, Zainab Clin Exp Dermatol Concise Reports Basal cell carcinoma (BCC) is an increasingly common cancer. For high‐risk BCCs, there are several treatment options, with similar efficacies. The current best practice in deciding upon a particular treatment is for a patient‐centred approach. At present, there are few resources available for patients to assist their choice. This reduces patient autonomy and increases the burden on clinicians within clinic. Patient decision aids (PDAs) have been shown to increase patient autonomy and facilitate shared decision‐making. Currently, there is no published PDA designed to facilitate the decision between surgical management or radiotherapy in high‐risk BCCs. We developed a novel decision aid designed along the International Patient Decision Aid Standards to fill this clinical need, and evaluated its acceptance by both patients and clinicians. We describe the challenges faced at initial alpha and subsequent beta testing, and go on to validate our PDA with both the Decisional Conflict Scale and the nine‐item Shared Decision Making Questionnaire (SDMQ9). We include an example of the PDA and encourage other units to modify the PDA for their own use. John Wiley and Sons Inc. 2022-08-12 2022-11 /pmc/articles/PMC9804260/ /pubmed/35799319 http://dx.doi.org/10.1111/ced.15325 Text en © 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Concise Reports
Banks, Jamie
Odili, Joy
Zaidi, Shane
Lalondrelle, Susan
Singh, Masha
Akhras, Victoria
Jiyad, Zainab
The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
title The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
title_full The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
title_fullStr The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
title_full_unstemmed The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
title_short The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
title_sort development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
topic Concise Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804260/
https://www.ncbi.nlm.nih.gov/pubmed/35799319
http://dx.doi.org/10.1111/ced.15325
work_keys_str_mv AT banksjamie thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT odilijoy thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT zaidishane thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT lalondrellesusan thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT singhmasha thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT akhrasvictoria thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT jiyadzainab thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT banksjamie developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT odilijoy developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT zaidishane developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT lalondrellesusan developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT singhmasha developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT akhrasvictoria developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma
AT jiyadzainab developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma